Alivus Life Sciences Limited — Others, 23-06-2025: Shareholders meeting

Alivus Life Sciences Limited has announced a postal ballot seeking shareholder approval for the re-appointment of Mrs. Manju Agarwal and Mr. Taruvai Laxminarayanan Easwar as Independent Directors for a second five-year term. Both directors bring extensive industry and governance experience; Mrs. Agarwal holds over three decades in banking and serves on multiple boards, while Mr. Easwar has a strong pharmaceutical operations background including leadership roles at Aurobindo Pharma and consultancy with BCG. Their continued presence on the Board supports Alivus’s governance strength and strategic oversight. Voting will be conducted electronically with results to be declared post completion.